Dyne Therapeutics (DYN) Treasury Shares (2019 - 2026)

Dyne Therapeutics' Treasury Shares history runs 8 years deep, the most recent figure standing at $4.6 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 53.02% year-over-year to $4.6 million; the TTM figure through Mar 2026 stood at $4.6 million (up 53.02% YoY), while the FY2025 annual figure was $2.4 million, down 34.49% from the prior year.
• Treasury Shares was $4.6 million for Q1 2026 at Dyne Therapeutics, up from $2.4 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $4.6 million in Q1 2026 to a low of $2462.0 in Q3 2022.
• Historically, Treasury Shares has averaged $2.3 million across 5 years, with a median of $2.6 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Treasury Shares tumbled 99.56% in 2022, then jumped 56003.13% in 2023.
• A 5-year view of Treasury Shares shows it stood at $1.7 million in 2022, then surged by 101.88% to $3.4 million in 2023, then climbed by 8.76% to $3.7 million in 2024, then plunged by 34.49% to $2.4 million in 2025, then jumped by 90.24% to $4.6 million in 2026.
• The last three Treasury Shares figures came in at $4.6 million (Q1 2026), $2.4 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.